Infection
In acute myeloid leukemia, the production of abnormal white blood cells in the bone marrow leads to a compromised immune system. While white blood cells are essential for protecting the body against harmful organisms, the abnormal cells produced in this condition have no function in defending the body. Instead, they grow rapidly and accumulate in the bone marrow, hindering the production of healthy white blood cells. Consequently, individuals with acute myeloid leukemia have a weakened immune system and are more susceptible to illnesses compared to those who are healthy.
Bleeding: Understanding the Impact of Abnormal Cells on Clot Formation
When abnormal cells start to overcrowd the bone marrow, the production of platelets is significantly reduced. Platelets are crucial for clot formation, which is essential in stopping bleeding. This decrease in platelet count is scientifically referred to as “thrombocytopenia.” As a result, individuals may experience petechiae, bleeding from the gums, nose, and even under the skin. Petechiae are characterized by small red spots on the skin or mucous membrane, caused by bleeding from tiny capillary vessels.
It is worth noting that small petechiae can sometimes merge, forming larger purple or blue spots known as ecchymoses. In the case of acute myeloid leukemia, bleeding may occur even from minor trauma, and it may take longer for the bleeding to stop.